Antiepileptic drugs: Impacts on human serum paraoxonase‐1
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Biochemical and Molecular Toxicology"
DOI: 10.1002/jbt.21889
Abstract: Serum paraoxonase (PON1) is a key enzyme related to high‐density lipoprotein (HDL)‐cholesterol particle. It can prevent the oxidation of low‐density lipoprotein (LDL) and HDL. The present article focuses on the in vitro inhibition role of… read more here.
Keywords: serum paraoxonase; impacts human; human serum; drugs impacts ... See more keywords
Association of human serum paraoxonase‐1 with some respiratory drugs
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Biochemical and Molecular Toxicology"
DOI: 10.1002/jbt.22407
Abstract: In this study, we investigated the effects of certain respiratory drugs, which are mainly used on human serum paraoxonase‐1 (hPON1; EC 3.1.8.1). hPON1 was purified from human serum, with 354.91 fold and 45% yield by… read more here.
Keywords: association human; human serum; serum paraoxonase; respiratory drugs ... See more keywords
Association between serum paraoxonase 1 activity and its polymorphisms with multiple sclerosis: a systematic review
Sign Up to like & getrecommendations! Published in 2020 at "Neurological Sciences"
DOI: 10.1007/s10072-020-04842-3
Abstract: Human serum paraoxonase (PON) is an enzyme that is synthesized by the liver and enters the bloodstream, and it is transmitted by high-density lipoproteins (HDL). Paraoxonase 1 (PON1) is a hydrolytic enzyme with a wide… read more here.
Keywords: sclerosis; serum paraoxonase; pon1; multiple sclerosis ... See more keywords